Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-025143
Filing Date
2017-11-01
Accepted
2017-11-01 19:37:10
Documents
2
Period of Report
2017-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3150
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4272
  Complete submission text file 0000899243-17-025143.txt   8925
Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
THOMAS FRANK E (Reporting) CIK: 0001242616 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38266 | Film No.: 171170340

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations